Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Gyre Therapeutics Inc (GYRE)

Gyre Therapeutics Inc (GYRE)
6.58 x 2 9.28 x 2
Post-market by (Cboe BZX)
8.64 +0.24 (+2.86%) 04/22/25 [NASDAQ]
6.58 x 2 9.28 x 2
Post-market 8.74 +0.10 (+1.16%) 19:27 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
8.26
Day High
8.89
Open 8.44
Previous Close 8.40 8.40
Volume 149,100 149,100
Avg Vol 197,140 197,140
Stochastic %K 79.86% 79.86%
Weighted Alpha -42.33 -42.33
5-Day Change +0.92 (+11.92%) +0.92 (+11.92%)
52-Week Range 6.11 - 19.00 6.11 - 19.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 786,341
  • Shares Outstanding, K 93,612
  • Annual Sales, $ 105,760 K
  • Annual Income, $ 12,090 K
  • EBIT $ 16 M
  • EBITDA $ 18 M
  • 60-Month Beta 2.03
  • Price/Sales 7.86
  • Price/Cash Flow 44.96
  • Price/Book 8.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.03
  • Number of Estimates 1
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.11 +41.41%
on 04/09/25
Period Open: 9.71
9.98 -13.38%
on 03/24/25
-1.07 (-11.02%)
since 03/21/25
3-Month
6.11 +41.41%
on 04/09/25
Period Open: 10.70
13.75 -37.16%
on 03/07/25
-2.06 (-19.25%)
since 01/22/25
52-Week
6.11 +41.41%
on 04/09/25
Period Open: 15.96
19.00 -54.53%
on 11/12/24
-7.32 (-45.86%)
since 04/22/24

Most Recent Stories

More News
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications

GYRE : 8.64 (+2.86%)
Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology

GYRE : 8.64 (+2.86%)
Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GYRE : 8.64 (+2.86%)
Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

GYRE : 8.64 (+2.86%)
Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

GYRE : 8.64 (+2.86%)
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

GYRE : 8.64 (+2.86%)
Is It Time to Buy the Nasdaq's 5 Worst-Performing Stocks in February 2024?

Some Nasdaq stocks are soaring in 2024, but these five charts are down by 40% or more. Are any of these struggling stocks actually good buys at a low price?

COMP : 6.95 (+1.31%)
BTC : 40.56 (+4.75%)
BABA : 115.88 (+5.20%)
$NASX : 16,300.42 (+2.71%)
GYRE : 8.64 (+2.86%)
SGML : 7.67 (+9.57%)
HUT : 11.79 (+10.81%)
GDS : 22.40 (+5.61%)
TCEHY : 60.1000 (+3.58%)
CIFR : 2.74 (+17.09%)
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?

These stocks are coming off a banner month, but what about the road ahead?

IXHL : 0.5610 (-4.92%)
GYRE : 8.64 (+2.86%)
KRRO : 16.33 (+19.72%)

Business Summary

Gyre Therapeutics Inc. is a biotechnology company. It focused on organ fibrosis and inflammatory diseases. The company's product pipeline primarily includes F573, F528 and F230. Gyre Therapeutics Inc., formerly known as Catalyst Biosciences Inc., is based in United States.

See More

Key Turning Points

3rd Resistance Point 9.56
2nd Resistance Point 9.23
1st Resistance Point 8.93
Last Price 8.64
1st Support Level 8.30
2nd Support Level 7.97
3rd Support Level 7.67

See More

52-Week High 19.00
Fibonacci 61.8% 14.08
Fibonacci 50% 12.56
Fibonacci 38.2% 11.03
Last Price 8.64
52-Week Low 6.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro